U.S. Patent Disclosures
Friday, November 16, 2012
AnaptysBio Inc., of San Diego, received U.S. Patent No. 8,288,160, titled "Activation Induced Deaminase (AID)," covering the use of in vitro somatic hypermutation in eukaryotic cells for the discovery and optimization of antibodies.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.